CompletedNot applicableNCT00207753

Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections

Studying Ankylostomiasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention
Principal Investigator
Michael J Beach, Ph.D.
Centers for Disease Control and Prevention
Intervention
albendazole vs. combined albendazole/ivermectin treatment(drug)
Enrollment
550 enrolled
Eligibility
5-12 years · All sexes
Timeline
20052005

Study locations (1)

Collaborators

Universidad del Valle, Guatemala

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00207753 on ClinicalTrials.gov

Other trials for Ankylostomiasis

Additional recruiting or active studies for the same condition.

See all trials for Ankylostomiasis

← Back to all trials